UBS Group’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-146,035
| Closed | -$7.46M | – | 9494 |
|
|
2024
Q4 | $7.46M | Buy |
146,035
+65,566
| +81% | +$3.35M | ﹤0.01% | 2624 |
|
|
2024
Q3 | $3.32M | Buy |
80,469
+58,044
| +259% | +$2.39M | ﹤0.01% | 2611 |
|
|
2024
Q2 | $1.08M | Sell |
22,425
-13,499
| -38% | -$650K | ﹤0.01% | 3339 |
|
|
2024
Q1 | $1.72M | Sell |
35,924
-8,417
| -19% | -$404K | ﹤0.01% | 3097 |
|
|
2023
Q4 | $2.88M | Buy |
44,341
+21,444
| +94% | +$1.39M | ﹤0.01% | 2523 |
|
|
2023
Q3 | $1.5M | Sell |
22,897
-26,108
| -53% | -$1.71M | ﹤0.01% | 2781 |
|
|
2023
Q2 | $2.85M | Buy |
49,005
+22,625
| +86% | +$1.32M | ﹤0.01% | 2387 |
|
|
2023
Q1 | $1.63M | Buy |
26,380
+8,041
| +44% | +$496K | ﹤0.01% | 2774 |
|
|
2022
Q4 | $1.17M | Buy |
18,339
+14,896
| +433% | +$947K | ﹤0.01% | 3017 |
|
|
2022
Q3 | $250K | Buy |
3,443
+127
| +4% | +$9.22K | ﹤0.01% | 3893 |
|
|
2022
Q2 | $225K | Sell |
3,316
-4,645
| -58% | -$315K | ﹤0.01% | 3853 |
|
|
2022
Q1 | $722K | Sell |
7,961
-5,829
| -42% | -$529K | ﹤0.01% | 3510 |
|
|
2021
Q4 | $1.26M | Buy |
13,790
+10,609
| +334% | +$969K | ﹤0.01% | 3265 |
|
|
2021
Q3 | $258K | Buy |
3,181
+2,364
| +289% | +$192K | ﹤0.01% | 4112 |
|
|
2021
Q2 | $76K | Sell |
817
-4,832
| -86% | -$449K | ﹤0.01% | 5039 |
|
|
2021
Q1 | $605K | Buy |
5,649
+3,981
| +239% | +$426K | ﹤0.01% | 3793 |
|
|
2020
Q4 | $145K | Buy |
1,668
+1,040
| +166% | +$90.4K | ﹤0.01% | 4477 |
|
|
2020
Q3 | $43K | Sell |
628
-218
| -26% | -$14.9K | ﹤0.01% | 4912 |
|
|
2020
Q2 | $41K | Buy |
+846
| New | +$41K | ﹤0.01% | 5205 |
|